At the news
? BEARISHIMPACT 6/10 CLUSTER filed Mar 12, 2026 at 20:00 ET
Three executive insiders at Xenon Pharmaceuticals (XENE) sold shares worth over $550K in open-market transactions within a 2-day window, following the exercise of stock options. The sales represent a coordinated monetization of equity compensation, with the CEO accounting for over 70% of the total value sold.
- CEO Ian Mortimer sold $403,584 worth of shares in a single open-market transaction on March 13, 2026.
- Chief Legal Officer and Chief Medical Officer sold $74,112 and $77,867 respectively on March 13.
- All three executives exercised stock options (totaling 37,500 shares) on March 12 at $0 cost, immediately preceding the sales.
- Total open-market sales: $555,563 across 10,060 shares at $55.225 per share.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access